BIICX | CTHFX | BIICX / CTHFX | |
Total Expense Ratio | 0.57 | 0.75 | 76% |
Annual Report Gross Expense Ratio | 0.68 | 0.75 | 91% |
Fund Existence | 18 years | 13 years | - |
Gain YTD | 10.216 | 10.398 | 98% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 250 | 800,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 10.6B | 4.85B | 218% |
Annual Yield % from dividends | 5.72 | 3.12 | 183% |
Returns for 1 year | 8.84 | 7.91 | 112% |
Returns for 3 years | 35.05 | 31.18 | 112% |
Returns for 5 years | 30.88 | 15.37 | 201% |
Returns for 10 years | 66.16 | 44.99 | 147% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 64.33 | 0.94 | +1.49% |
ProShares Ultra Nasdaq Biotechnology | |||
RYSE | 22.56 | 0.03 | +0.13% |
Cboe Vest 10 Yr Intst Rt Hdg ETF | |||
RIV | 11.96 | 0.01 | +0.08% |
RiverNorth Opportunities Fund | |||
USXF | 57.80 | -0.05 | -0.08% |
iShares® ESG Advanced MSCI USA ETF | |||
PSQO | 20.62 | -0.02 | -0.09% |
Palmer Square Credit Opportunities ETF |